Evidence map›Paper›PMID 42549113›Full record

ArticleERJ open research2026

Single-cell RNA sequencing reveals aberrant airway epithelial-immune cell cross-talk in pulmonary fibrosis.

Richard J Hewitt, Probir Chakravarty, Jimena Perez-Lloret, Martin Banchero, Marijn Berg, Maarten van den Berge, William J Traves, Laura L Yates, Simone A Walker, David C A Gaboriau and 11 more

Abstract read
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Richard J HewittNational Heart and Lung Institute, Imperial College London, London, UK.
Probir ChakravartyThe Francis Crick Institute, Bioinformatics & Biostatistics STP, London, UK.ORCID https://orcid.org/0000-0003-1146-8824
Jimena Perez-LloretThe Francis Crick Institute, Advanced Sequencing Facility STP, London, UK.
Martin BancheroDepartment of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, the Netherlands.
Marijn BergDepartment of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, the Netherlands.
Maarten van den BergeDepartment of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, the Netherlands.
William J TravesNational Heart and Lung Institute, Imperial College London, London, UK.
Laura L YatesNational Heart and Lung Institute, Imperial College London, London, UK.
Simone A WalkerNational Heart and Lung Institute, Imperial College London, London, UK.
David C A GaboriauFacility for Imaging by Light Microscopy, Imperial College London, London, UK.
Alexandra RiceRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Andrew G NicholsonRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Anand DevarajNational Heart and Lung Institute, Imperial College London, London, UK.
Samuel V KempRoyal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0002-6639-0166
Philip L MolyneauxNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-1301-8800
Franz PutturNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-2058-8521
Adam J ByrneNational Heart and Lung Institute, Imperial College London, London, UK.
Toby M MaherNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-7192-9149
Martijn C NawijnDepartment of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, the Netherlands.ORCID https://orcid.org/0000-0003-3372-6521
Anne O'GarraNational Heart and Lung Institute, Imperial College London, London, UK.
Clare M LloydNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-8977-6726

Funding

HSRD VA CDA 13-017Wellcome Trust FC001126
6 · The paper itself

Abstract

Background: Epithelial-immune cell interactions are crucial in the regulation of pulmonary immune responses. Emerging evidence suggests that cell populations lining the airways may play a pivotal role in the pathogenesis of idiopathic pulmonary fibrosis (IPF), a disease characterised by progressive scarring of the lung parenchyma. We profiled the cellular landscape of the airway mucosal niche in incident cases of IPF to understand early-stage events contributing to disease development. Methods: Single-cell RNA-sequencing was used to explore cellular heterogeneity in proximal airway brushings from seven healthy controls and nine patients with newly diagnosed IPF. In-depth bioinformatics analysis was used to interrogate changes in cell populations and cell-cell communication in IPF patients compared to controls. Results: We show a relative increase in the abundance of airway macrophage subsets in IPF compared to healthy controls, and disease-specific changes in their transcriptional profile. Increased frequency of airway macrophages and proliferating macrophages was associated with more extensive disease at baseline quantified by the composite physiological index and radiological severity of traction bronchiectasis. Monocyte-derived macrophages were significantly enriched at baseline in IPF patients who had disease progression at 12 months. Using CellChat we exposed differences in cell-cell communication between airway epithelial cells, airway macrophages and T-cells in IPF. We identified dysregulation in signalling pathways such as SEMA3, ANXA1 and DESMOSOME, which modulate airway epithelial-macrophage interactions, potentially driving disease pathology. Conclusions: Airway epithelial cells and macrophages may play a key role in orchestrating the early immunopathology of IPF, and these data support further exploration of novel, airway-focused therapeutic targets in IPF.

Identifiers

PMID42549113
PMCPMC13430588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.